Oral Mucositis: Time for More Studies

References

• Bellm, L.A., Epstein, J.B., Rose-Ped, A., Martin, P. and Fuchs, H.J. (2000) "Patient reports of complications of bone marrow transplantation", Support. Care Cancer 8, 33–39.
   PubMed Web of Science ®Google Scholar
• Dodd, M.J., Dibble, S., Miaskowski, C., Paul, S., Cho, M., MacPhail, L., Greenspan, D. and Shiba, G. (2001) "A comparison of the affective state and quality of life of chemotherapy patients who do and do not develop chemotherapy-induced oral mucositis", I. Pain Symptom Manage. 21, 498–505.
   PubMed Web of Science ®Google Scholar
• Durrant, S.P.J.F.J., for the KGF BEAM Study group (2001). "Oral Mucositis reduced health related quality of life (HRQOL) in a phase 1 trial of lymphoma patients receiving high-dose chemotherapy with autologous PBPC transplan-tation". American Society of Hematology; 43rd Annual meeting, Orlando, FL.
   Google Scholar
• Stiff, P.S.R.E.D., Erder, M., Ford, J., for the KGF transplant study group (2001). "High correlations of mucositis health-related quality-of-life (HRQOL) questionnaire with oral mucositis (OM) grading systems in pts with hematologic malignancies receiving high-dose chemotherapy (HDC) and total body irradiation (TBI) with autologous PBPC transplan-tation (autoPBPCT)". American Society of Hematology; 43rd Annual meeting, Orlando, FL.
   Google Scholar
• Sonis, ST., Oster, G., Fuchs, H., Bellm, L., Bradford, W.Z., Edelsberg, J., Hayden, V, Eilers, J., Epstein, J.B., LeVeque, F.G., Miller, C., Peterson, D.E., Schubert, M.M., Spijkervet, F.K. and Horowitz, M. (2001) "Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell trans-plantation", J. Clin. Oncol. 19, 2201–2205.
   PubMed Web of Science ®Google Scholar
• Peterman, A., Cella, D., Glandon, G., Dobrez, D. and Yount, S. (2001) "Mucositis in head and neck cancer: economic and quality-of-life outcomes", J. Natl Cancer Inst. Monogr., 45–51.
   PubMedGoogle Scholar
• Kostler, W.J., Hejna, M., Wenzel, C. and Zielinski, C.C. (2001) "Oral mucositis complicating chemotherapy and/or radio-therapy: options for prevention and treatment", CA Cancer J. Clin. 51, 290–315.
   PubMed Web of Science ®Google Scholar
• NCI (1999). "National Cancer Institute Common Toxicity Criteria" (NCI-CTC).
   Google Scholar
• WHO (1979). "Handbook for reporting results of cancer treatment". World Health Organization.
   Google Scholar
• Sonis, S.T., Eilers, J.P., Epstein, J.B., LeVeque, F.G., Liggett, Jr., W.H., Mulagha, M.T., Peterson, D.E., Rose, A.H., Schubert, M.M., Spijkervet, F.K. and Wittes, J.P. (1999) "Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Mucositis Study Group", Cancer 85, 2103–2113.
   PubMed Web of Science ®Google Scholar
• Cella, D.F.H.M.C., Hurd, D., Wingard, JR., Fleming, T., Sonis, S., Anaissie, E., Martin, P., Giles, E (2001). "Evaluation of pain associated with oral mucositis (OM) using an 11-point likert scale by patients receiving myeloablative chemotherapy". American Society of Hematology; 43rd Annual meeting, Orlando, FL.
   Google Scholar
• Stiff, P. (2001) "Mucositis associated with stem cell transplantation: current status and innovative approaches to management", Bone Marrow Transplant. 27\(Suppl. 2), S3—S11.
   PubMedGoogle Scholar
• Sutherland, ST. and Browman, G.P. (2001) "Prophylaxis of oral mucositis in irradiated head-and-neck cancer patients: a proposed classification scheme of interventions and meta-analysis of randomized controlled trials", Int. J. Radiat. Oncol. Biol. Phys. 49, 917–930.
   PubMed Web of Science ®Google Scholar
• Khan, S.A. and Wingard, J.R. (2001) "Infection and mucosal injury in cancer treatment", J. Natl Cancer Inst. Monogr., 31–36.
   PubMedGoogle Scholar
• Perry, M. (2001) "The chemotherapy source book", Oral Toxicity.
   Google Scholar
• Wardley, A.M., Jayson, G.C., Swindell, R., Morgenstern, G.R., Chang, J., Bloor, R., Fraser, C.J. and Scarffe, J.H. (2000) "Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue", Br. J. Haematol. 110, 292–299.
   PubMed Web of Science ®Google Scholar
• Trotti, A. (2000) "Toxicity in head and neck cancer: a review of trends and issues", Int. J. Radiat. Oncol. Biol. Phys. 47, 1–12.
   PubMed Web of Science ®Google Scholar
• Squier, C.A. and Kremer, M.J. (2001) "Biology of oral mucosa and esophagus", J. Natl Cancer Inst. Monogr., 7–15.
   PubMedGoogle Scholar
• Williams, D.A. (2001) "Inflammatory cytokines and mucosal injury", J. Natl Cancer Inst. Monogr., 26–30.
   PubMedGoogle Scholar
• Panoskaltsis-Mortari, A., Taylor, P.A., Rubin, J.S., Uren, A., Welniak, L.A., Murphy, W.J., Farrell, C.L., Lacey, D.L. and Blazar, B.R. (2000) "Keratinocyte growth factor facilitates alloengraftment and ameliorates graft-versus-host disease in mice by a mechanism independent of repair of conditioning-induced tissue injury", Blood 96, 4350–4356.
   PubMed Web of Science ®Google Scholar
• Leung, W.K., Jin, L.J., Yam, W.C. and Samaranayake, L.P. (2001) "Oral colonization of aerobic and facultatively anaerobic gram-negative rods and cocci in irradiated, dentate, xerostomic individuals", Oral Microbiol. Immunol. 16, 1–9.
   PubMedGoogle Scholar
• Zinner, S.H. (2000) "New pathogens in neutropenic patients with cancer: an update for the new millennium", Int. J. Antimicrob. Agents 16, 97–101.
   PubMed Web of Science ®Google Scholar
• Anaissie, E.P.J.M.C., Hurd, D., Wingard, J., Fleming, T., Sonis, S., Martin, P., Fuchs, H., Giles, E (2001). "Risk factors for infectious morbidity and mortality in patients with hemato-logical malignancies receiving myeloablative chemotherapy: the importance of mucositis". American Society of Hematology; 43rd Annual meeting, Orlando, FL.
   Google Scholar
• Schuster, G.S. (1999) "Oral flora and pathogenic organisms", Infect. Dis. Clin. North Am. 13, 757–774.
   PubMed Web of Science ®Google Scholar
• Epstein, J.B. and Chow, A.W. (1999) "Oral complications associated with immunosuppression and cancer therapies", Infect. Dis. Clin. North Am. 13, 901–923.
   PubMed Web of Science ®Google Scholar
• Pico, J.L., Avila-Garavito, A. and Naccache, P. (1998) "Mucositis: its occurrence, consequences, and treatment in the oncology setting", Oncologist 3, 446–451.
   PubMedGoogle Scholar
• Miaskowski, C. (2001) "Biology of mucosal pain", J. Natl. Cancer Inst. Monogr., 37–40.
   PubMedGoogle Scholar
• Larson, P.J., Miaskowski, C., MacPhail, L., Dodd, M.J., Greenspan, D., Dibble, S.L., Paul, S.M. and Ignoffo, R. (1998) "The PRO-SELF mouth aware program: an effective approach for reducing chemotherapy-induced mucositis", Cancer Nurs. 21, 263–268.
   PubMed Web of Science ®Google Scholar
• Biron, P., Sebban, C., Gourmet, R., Chvetzoff, G., Philip, I. and Blay, J.Y. (2000) "Research controversies in management of oral mucositis", Support. Care Cancer 8, 68–71.
   PubMed Web of Science ®Google Scholar
• Dodd, M.J., Dibble, S.L., Miaskowski, C., MacPhail, L., Greenspan, D., Paul, S.M., Shiba, G. and Larson, P. (2000) "Randomized clinical trial of the effectiveness of 3 commonly used mouthwashes to treat chemotherapy-induced mucosi-tis", Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 90, 39–47.
   PubMed Web of Science ®Google Scholar
• Worthington, H.V., Clarkson, J.E., Eden, O.B. (2002). "Inter-ventions for treating oral mucositis for patients with cancer receiving treatment". Cochrane Database Syst. Rev. 1.
   Google Scholar
• Rahn, R., Adamietz, LA., Boettcher, H.D., Schaefer, V, Reimer, K. and Fleischer, W. (1997) "Povidone—iodine to prevent mucositis in patients during antineoplastic radiochemothe-rapy", Dermatology 195\(Suppl. 2), 57–61.
   PubMedGoogle Scholar
• Adamietz, LA., Rahn, R., Bottcher, H.D., Schafer, V, Reimer, K. and Fleischer, W. (1998) "Prophylaxis with povidone—iodine against induction of oral mucositis by radiochemo-therapy", Support. Care Cancer 6, 373–377.
   PubMed Web of Science ®Google Scholar
• Peterson, D.E. and Sonis, S.T. (2001) "Future research directions", J. Natl Cancer Inst. Monogr., 3–5.
   PubMedGoogle Scholar
• Lee, V.H. (2001) "Mucosal drug delivery", J. Natl Cancer Inst. Monogr., 41–44.
   PubMedGoogle Scholar
• Bellm, L.A., Epstein, J.B., Rose-Ped, A.M., Fu, R., Martin, P.J. and Fuchs, H.J. (2001) "Assessment of various topical oral formulations by bone marrow transplant recipients", Oral Oncol. 37, 42–49.
   PubMed Web of Science ®Google Scholar
• Beer, H.D., Gassmann, M.G., Munz, B., Steiling, H., Engelhardt, F., Bleuel, K. and Werner, S. (2000) "Expression and function of keratinocyte growth factor and activin in skin morphogenesis and cutaneous wound repair", J. Investig. Dermatol. Symp. Proc. 5, 34–39.
   PubMed Web of Science ®Google Scholar
• Booth, D. and Potten, C.S. (2001) "Protection against mucosal injury by growth factors and cytokines", J. Natl Cancer Inst. Monogr., 16–20.
   PubMedGoogle Scholar
• Farrell, C.L., Rex, K.L., Kaufman, S.A., Dipalma, C.R., Chen, J.N., Scully, S. and Lacey, D.L. (1999) "Effects of keratinocyte growth factor in the squamous epithelium of the upper aerodigestive tract of normal and irradiated mice", Int. J. Radiat. Biol. 75, 609–620.
   PubMed Web of Science ®Google Scholar
• Dorr, W., Noack, R., Spekl, K. and Farrell, C.L. (2001) "Modification of oral mucositis by keratinocyte growth factor: single radiation exposure", Int. J. Radiat. Biol. 77, 341–347.
   PubMed Web of Science ®Google Scholar
• Krijanovski, O.I., Hill, G.R., Cooke, K.R., Teshima, T., Crawford, J.M., Brinson, YS. and Ferrara, J.L. (1999) "Keratinocyte growth factor separates graft-versus-leuke-mia effects from graft-versus-host disease", Blood 94, 825–831.
   PubMed Web of Science ®Google Scholar
• Freytes, C.L.F.M.B., Taylor, C., Ratanatharathorn, V, Schubert, M., Odenheimer, D., Chesser, N., Navarro, W., Khan, S., de Magalhaes-Silverman, M., Abboud, C., Costa, J. (2001). "Safety and efficacy of repifermin (KGF-2) in reducing mucositis in patients undergoing autologous hematopoietic stem cell transplantation (auto-HSCT)- results of a phase 2a trial". American Society of Hematology; 43rd Annual meeting, Orlando, FL.
   Google Scholar
• Giles, F.J., Redman, R., Yazji, S. and Bellm, L. (2002) "Iseganan HO: a novel antimicrobial agent", Expert Opin. Investig. Drugs 11, 1161–1170.
   PubMed Web of Science ®Google Scholar
• Heller, W.T., Waring, A.J., Lehrer, R.I., Harroun, T.A., Weiss, T.M., Yang, L. and Huang, H.W. (2000) "Membrane thinning effect of the beta-sheet antimicrobial protegrin", Biochemistry 39, 139–145.
   PubMed Web of Science ®Google Scholar
• Chen, J., Falla, T.J., Liu, H., Hurst, M.A., Fujii, C.A., Mosca, D.A., Embree, J.R., Loury, D.J., Radel, P.A., Cheng Chang, C., Gu, L. and Fiddes, J.C. (2000) "Development of protegrins for the treatment and prevention of oral mucositis: structure—activity relationships of synthetic protegrin analogues", Biopolymers 55, 88–98.
   PubMed Web of Science ®Google Scholar
• Steinstraesser, L., Klein, RD., Aminlari, A., Fan, M.H., Khilanani, V, Remick, D.G., Su, G.L. and Wang, S.C. (2001) "Protegrin-1 enhances bacterial killing in thermally injured skin", Crit. Care Med. 29, 1431–1437.
   PubMed Web of Science ®Google Scholar
• Mosca, D.A., Hurst, MA., So, W., Viajar, B.S., Fujii, CA. and Falla, T.J. (2000) "TB-367, a protegrin peptide with in vitro and in vivo activities against the microflora associated with oral mucositis", Antimicrob. Agents Chemother. 44, 1803–1808.
   PubMed Web of Science ®Google Scholar
• Giles, F.J. (1998) "Monocyte-macrophages, granulocyte-macrophage colony-stimulating factor, and prolonged survi-val among patients with acute myeloid leukemia and stem cell transplants", Clin. Infect. Dis. 26, 1282–1289.
   PubMed Web of Science ®Google Scholar
• Koukourakis, MI., Flordellis, CS., Giatromanolaki, A., Koukouraki, S., Kapsoritakis, A., Potamianos, S., Retalis, G., Sivridis, E., Salsaa, B., Harris, A.L. and Maragoudakis, M.I. (1999) "Oral administration of recombinant human granulo-cyte macrophage colony-stimulating factor in the manage-ment of radiotherapy-induced esophagitis", Clin. Cancer Res. 5, 3970–3976.
   PubMed Web of Science ®Google Scholar
• Makkonen, T.A., Minn, H., Jekunen, A., Vilja, P., Tuominen, J. and Joensuu, H. (2000) "Granulocyte macrophage-colony stimulating factor (GM-CSF) and sucralfate in prevention of radiation-induced mucositis: a prospective randomized study", Int. J. Radiat. Oncol. Biol. Phys. 46, 525–534.
   PubMed Web of Science ®Google Scholar
• Gordon, B., Spadinger, A., Hodges, E., Ruby, E., Stanley, R. and Coccia, P. (1994) "Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis after hemato-poietic stem-cell transplantation", J. Clin. Oncol. 12, 1917–1922.
   PubMed Web of Science ®Google Scholar
• Chi, K.H., Chen, C.H., Chan, W.K., Chow, K.C., Chen, S.Y., Yen, S.H., Chao, J.Y., Chang, C.Y. and Chen, K.Y. (1995) "Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil, and leucovorin chemotherapy", J. Clin. Oncol. 13, 2620–2628.
   PubMed Web of Science ®Google Scholar
• Mascarin, M., Franchin, G., Minatel, E., Gobitti, C., Talamini, R., De Maria, D. and Trovo, M.G. (1999) "The effect of granulocyte colony-stimulatingfactor on oral mucositis in head and neck cancer patients treated with hyperfractionated radiotherapy", Oral Oncol. 35, 203–208.
   PubMed Web of Science ®Google Scholar
• Sprinzl, G.M., Galvan, O., de Vries, A., Ulmer, H., Gunkel, A.R., Lukas, P. and Thumfart, W.F. (2001) "Local application of granulocyte-macrophage colony stimulating factor (GM-CSF) for the treatment of oral mucositis", Fur. J. Cancer 37, 2003–2009.
   Web of Science ®Google Scholar
• Valcarcel, D.S.M.S.A., Sala, M., Munoz, L., Subira, M., Clopes, A., Sierra, J. (2001). "Mouth washings with granulocyte-maccrophage colony stimulating factor do not improve oropharyngeal mucositis in patients undergoing stem cell marrow transplantation". Results of a randomized prospective double-blind study.
   Google Scholar
• Hejna, M., Kostler, W.J., Raderer, M., Steger, G.G., Brodowicz, T., Scheithauer, W., Wiltschke, C. and Zielinski, C.C. (2001) "Decrease of duration and symptoms in chemotherapy-induced oral mucositis by topical GM-CSF: results of a prospective randomised trial", Fur. J. Cancer 37, 1994–2002.
   Web of Science ®Google Scholar
• Nicolatou-Galitis, O., Dardoufas, K., Markoulatos, P., Sotir-opoulou-Lontou, A., Kyprianou, K., Kolitsi, G., Pissakas, G., Skarleas, C., Kouloulias, V, Papanicolaou, V, Legakis, N.J. and Velegraki, A. (2001) "Oral pseudomembranous candi-diasis, herpes simplex virus-1 infection, and oral mucositis in head and neck cancer patients receiving radiotherapy andgranulocyte-macrophagecolony-stimulatingfactor (GM-CSF) mouthwash", J. Oral. Pathol. Med. 30, 471–480.
   PubMed Web of Science ®Google Scholar
• Karthaus, M., Rosenthal, C., Huebner, G., Paul, H., Elser, C., Hertenstein, B., Krauter, J., Scharmann, T., Geissler, R.G., Heil, G. and Ganser, A. (1998) "Effect of topical oral G-CSF on oral mucositis: a randomised placebo-controlled trial", Bone Marrow Transplant. 22, 781–785.
   PubMed Web of Science ®Google Scholar
• Capelli, D., Santini, G., De Souza, C., Poloni, A., Marino, G., Montanan, M., Lucesole, M., Brunori, M., Massidda, D., Offidani, M., Leoni, P. and Olivieri, A. (2000) "Amifostine can reduce mucosal damage after high-dose melphalan con-ditioning for peripheral blood progenitor cellautotransplant: a retrospective study", Br. J. Haematol. 110, 300–307.
   PubMed Web of Science ®Google Scholar
• Brizel, D.M., Wasserman, T.H., Henke, M., Strnad, V, Rudat, V, Monnier, A., Eschwege, F., Zhang, J., Russell, L., Oster, W. and Sauer, R. (2000) "Phase ifi randomized trial of amifostine as a radioprotector in head and neck cancer", J. Clin. Oncol. 18, 3339–3345.
   PubMed Web of Science ®Google Scholar
• Koukourakis, MI., Kyrias, G., Kakolyris, S., Kouroussis, C., Frangiadaki, C., Giatromanolaki, A., Retalis, G. and Georgoulias, V. (2000) "Subcutaneous administration of amifostine during fractionated radiotherapy: a randomized phase II study", J. Clin. Oncol. 18, 2226–2233.
   PubMed Web of Science ®Google Scholar
• Campilho, F.M.C.A.V.C., Barbosa, I., Roncon, S., Carvalhais, A., Pimentel, P.M. (2001). "Amifostine (AMI) before high-dose melphalan (HDMel) and Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for patients with multiple myeloma (MM)—a case control analysis". American Society of Hematology; 43rd Annual meeting, Orlando, FL.
   Google Scholar
• Epstein, J.B., Silverman, Jr., S., Paggiarino, D.A., Crockett, S., Schubert, M.M., Senzer, N.N., Lockhart, P.B., Gallagher, M.J., Peterson, D.E. and Leveque, E.G. (2001) "Benzydamine HC1 for prophylaxis of radiation-induced oral mucositis: results from a multicenter, randomized, double-blind, placebo-controlled clinical trial", Cancer 92, 875–885.
   PubMed Web of Science ®Google Scholar
• Estey, E.H., Thall, P.F., Giles, F.J., Wang, X.M., Cortes, J.E., Beran, M., Pierce, S.A., Thomas, D.A. and Kantarjian, H.M. (2002) "Gemtuzumab ozogamicin with or without interleukin 11 in patients 65 years of age or older with untreated acute myeloid leukemia and high-risk myelodysplastic syndrome: comparison with idarubicin plus continuous-infusion, high-dose cytosine arabinoside", Blood 99, 4343–4349.
   PubMed Web of Science ®Google Scholar
• Sonis, ST., Peterson, R.L., Edwards, L.J., Lucey, C.A., Wang, L., Mason, L., Login, G., Ymamkawa, M., Moses, G., Bouchard, E, Hayes, L.L., Bedrosian, C. and Dorner, A.J. (2000) "Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters", Oral Oncol. 36, 373–381.
   PubMed Web of Science ®Google Scholar
• Etiz, D., Erkal, H.S., Serin, M., Kucuk, B., Hepari, A., Elhan, A.H., Tulunay, O. and Cakmak, A. (2000) "Clinical and histopathological evaluation of sucralfate in prevention of oral mucositis induced by radiation therapy in patients with head and neck malignancies", Oral Oncol. 36, 116–120.
   PubMed Web of Science ®Google Scholar
• Castagna, L., Benhamou, E., Pedraza, E., Luboinski, M., Form, M., Brandes, I., Pico, J.L. and Dietrich, P.Y. (2001) "Prevention of mucositis in bone marrow transplantation: a double blind randomised controlled trial of sucralfate", Ann. Oncol. 12, 953–955.
   PubMed Web of Science ®Google Scholar
• Okuno, S.H., Foote, R.L., Loprinzi, CL., Gulavita, S., Sloan, J.A., Earle, J., Novotny, P.J., Burk, M. and Frank, A.R. (1997) "A randomized trial of a nonabsorbable antibiotic lozenge given to alleviate radiation-induced mucositis", Cancer 79, 2193–2199.
   PubMed Web of Science ®Google Scholar
• Symonds, R.P., Maroy, P., Khorrami, J., Paul, J., Pyper, E., Alcock, SR., McCallum, I., Speekenbrink, A.B., McMurray, A., Lindemann, E. and Thomas, M. (1996) "The reduction of radiation mucositis by selective decontamination antibiotic pastilles: a placebo-controlled double-blind trial", Br. J. Cancer 74, 312–317.
   PubMed Web of Science ®Google Scholar
• El-Sayed, S., Epstein, J., Minish, E., Burns, P., Hay, J. and Lauldcanen, E. (2002) "A pilot study evaluating the safety and microbiologic efficacy of an economically viable antimicrobial lozenge in patients with head and neck cancer receiving radiation therapy", Head Neck. 24, 6–15.
   PubMed Web of Science ®Google Scholar
• Wijers, O.B., Levendag, P.C., Harms, KR., Gan-Teng, A.M., Schmitz, P.I., Hendriks, W.D., Wilims, E.B., van der Est, H. and Visch, L.L. (2001) "Mucositis reduction by selective elimination of oral flora in irradiated cancers of the head and neck: a placebo-controlled double-blind randomized study", Int. J. Radiat. Oncol. Biol. Phys. 50, 343–352.
   PubMed Web of Science ®Google Scholar
• Gujral, US., Patnaik, P.M., Kaul, R., Parikh, H.K., Conradt, C., Tamhankar, C.P. and Daftary, G.V. (2001) "Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers", Cancer Chemother. Pharmacol. 47, S23—S28.
   PubMed Web of Science ®Google Scholar
• Goldberg, S.P.L.S.M., MacCarthy, P., Fruchtman, S., Stadtmauer, E., Libin, B. (2001). "Randomized, vehicle controlled study of immunol oral rinse for the prevention of oral mucositis in bone marrow transplant patients undergoing intensive chemotherapy and/or radiotherapy". American Society of Hematology; 43rd Annual meeting, Orlando, FL.
   Google Scholar